08. Medicines: new game, new rules - Pathways to better and affordable medicines

Organised by Open Society Foundations in cooperation with European Public Health Alliance (EPHA) and European Public Health Association (EUPHA) 2016 was a year of political recognition that imbalances exist in the pharmaceutical system along with widespread concerns about the sustainability of healthcare systems in Europe. The price of both old and new medicines has been rising dramatically, leading to rationing of medicines for patients and other access to treatment challenges. These problems are the result of a dysfunctional R&D system that prioritises profits over public health imperatives and individual patients’ needs. This session will respond to the calls by EU and national policy-makers for actionable policy recommendations. It will articulate a set of short, mid and long-term policy proposals in the area of incentives for drug development and the need for public health needs-driven regulatory reform in Europe, to guarantee genuine therapeutic advance for the benefit of all patients. Full programme available online: https://www.ehfg.org/archive/2017/conference/ehfg2017/f5/